Advocating for FH from Florida to Washington D.C.
n May 7, 2019 FH Advocate, April Donelson, chose to spend her birthday on Capitol Hill, advocating to make familial hypercholesterolemia (FH) a public health priority with Florida [...]
Action Alert: Getting the Lower List Price for PCSK9 inhibitors
Ask the Pharmacy – Are you getting the lowest cost for your PCSK9 inhibitor? The manufacturers of both PCSK9 inhibitors, Praluent and Repatha, have lowered the list price for [...]
Sanofi and Regeneron lower list price for PCSK9 inhibitor
the Family Heart Foundation welcomes Sanofi and Regeneron’s announcement today to lower the list price of its LDL cholesterol lowering treatment, the PCSK9 inhibitor Praluent, to $5,850 annually. This brings the [...]
Advancing FH Care at NHLBI Workshop on Implementation Science and FH
Katherine Wilemon, Founder and CEO, Cat Davis Ahmed, Vice President of Policy and Outreach, and several Family Heart Foundation board members participated in a workshop convened by the National [...]
Family Heart Foundation Driving Global Policy Collaboration in Dubai
Global Call to Action on FH Roundtable the Family Heart Foundation is thrilled to continue the Global Call to Action on FH initiative during the 2018 World Congress of Cardiology [...]
